Literature DB >> 10400320

Bioorganic chemistry of cyclic ADP-ribose (cADPR).

F J Zhang1, Q M Gu, C J Sih.   

Abstract

The objective of this brief review is to present an overview of the bioorganic chemistry of cyclic-ADP-ribose (cADPR) with special emphasis on the methodology used for the synthesis of analogues of cADPR. New structural analogues of cADPR can be prepared using either the biomimetic method or ADP-ribosyl cyclase from Aplysia californica. For the most part, both procedures give similar product profiles, but higher yields are generally obtained with the enzymatic method. These synthetic methodologies have allowed the transformation of a variety of structurally modified analogues of NAD+ into their corresponding cyclic nucleotides. Several of these novel analogues are more potent than cADPR in inducing calcium release and are also more stable towards degradative enzymes. They could serve as valuable affinity probes for the isolation of cADPR-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400320     DOI: 10.1016/s0968-0896(98)00256-9

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Design, Synthesis, and Chemical and Biological Properties of Cyclic ADP-4-Thioribose as a Stable Equivalent of Cyclic ADP-Ribose.

Authors:  Takayoshi Tsuzuki; Satoshi Takano; Natsumi Sakaguchi; Takashi Kudoh; Takashi Murayama; Takashi Sakurai; Minako Hashii; Haruhiro Higashida; Karin Weber; Andreas H Guse; Tomoshi Kameda; Takatsugu Hirokawa; Yasuhiro Kumaki; Mitsuhiro Arisawa; Barry V L Potter; Satoshi Shuto
Journal:  Messenger (Los Angel)       Date:  2014-06-01

2.  Unifying mechanism for Aplysia ADP-ribosyl cyclase and CD38/NAD(+) glycohydrolases.

Authors:  C Cakir-Kiefer; H Muller-Steffner; F Schuber
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

3.  Synthesis of cyclic adenosine 5'-diphosphate ribose analogues: a C2'endo/syn "southern" ribose conformation underlies activity at the sea urchin cADPR receptor.

Authors:  Christelle Moreau; Gloria A Ashamu; Victoria C Bailey; Antony Galione; Andreas H Guse; Barry V L Potter
Journal:  Org Biomol Chem       Date:  2010-10-25       Impact factor: 3.876

4.  Aberrant cyclization affords a C-6 modified cyclic adenosine 5'-diphosphoribose analogue with biological activity in Jurkat T cells.

Authors:  Christelle Moreau; Tanja Kirchberger; Bo Zhang; Mark P Thomas; Karin Weber; Andreas H Guse; Barry V L Potter
Journal:  J Med Chem       Date:  2012-02-08       Impact factor: 7.446

5.  Synthesis and Biological Evaluation of a New Structural Simplified Analogue of cADPR, a Calcium-Mobilizing Secondary Messenger Firstly Isolated from Sea Urchin Eggs.

Authors:  Stefano D'Errico; Nicola Borbone; Bruno Catalanotti; Agnese Secondo; Tiziana Petrozziello; Ilaria Piccialli; Anna Pannaccione; Valeria Costantino; Luciano Mayol; Gennaro Piccialli; Giorgia Oliviero
Journal:  Mar Drugs       Date:  2018-03-10       Impact factor: 5.118

Review 6.  Does Cyclic ADP-Ribose (cADPR) Activate the Non-selective Cation Channel TRPM2?

Authors:  Ralf Fliegert; Winnie M Riekehr; Andreas H Guse
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

7.  Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-N1-inosine 5'-monophosphate, Analogues and Early Structure-Activity Relationship.

Authors:  Joanna M Watt; Richard Graeff; Barry V L Potter
Journal:  Molecules       Date:  2021-11-26       Impact factor: 4.411

8.  CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose Template.

Authors:  Christelle Moreau; Qun Liu; Richard Graeff; Gerd K Wagner; Mark P Thomas; Joanna M Swarbrick; Satoshi Shuto; Hon Cheung Lee; Quan Hao; Barry V L Potter
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

9.  Identification of a nicotinamide/nicotinate mononucleotide adenylyltransferase in Giardia lamblia (GlNMNAT).

Authors:  Nicolás Forero-Baena; Diana Sánchez-Lancheros; July Constanza Buitrago; Victor Bustos; María Helena Ramírez-Hernández
Journal:  Biochim Open       Date:  2015-11-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.